Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Net Cash Flow (2020 - 2025)

NeuroPace has reported Net Cash Flow over the past 6 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $1.0 million for Q4 2025, up 153.2% from a year ago — trailing twelve months through Dec 2025 was $8.3 million (up 278.52% YoY), and the annual figure for FY2025 was $8.3 million, up 278.52%.
  • Net Cash Flow for Q4 2025 was $1.0 million at NeuroPace, up from -$2.2 million in the prior quarter.
  • Over the last five years, Net Cash Flow for NPCE hit a ceiling of $17.1 million in Q2 2021 and a floor of -$12.5 million in Q1 2021.
  • Median Net Cash Flow over the past 5 years was -$73500.0 (2022), compared with a mean of -$248650.0.
  • Biggest five-year swings in Net Cash Flow: soared 5225.71% in 2023 and later crashed 4475.65% in 2024.
  • NeuroPace's Net Cash Flow stood at -$7.4 million in 2021, then skyrocketed by 111.9% to $886000.0 in 2022, then surged by 845.94% to $8.4 million in 2023, then crashed by 123.15% to -$1.9 million in 2024, then skyrocketed by 153.2% to $1.0 million in 2025.
  • The last three reported values for Net Cash Flow were $1.0 million (Q4 2025), -$2.2 million (Q3 2025), and -$4.1 million (Q2 2025) per Business Quant data.